RHEOS MEDICINES

rheos-medicines-logo

Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease. Their approach targets the underlying cellular metabolism of immune cells to redirect the fate and function of specific cell types to treat immune-mediated disease. By simultaneously identifying new drug targets and characterizing biomarkers of disease they are bringing precision to the treatment of immune-mediated diseases. They have brought together leading scientists whose discoveries opened the field of immunometabolism, clinicians with a deep understanding of immune-mediated diseases, and an experienced biotech leadership team.

#SimilarOrganizations #People #Financial #Event #Website #More

RHEOS MEDICINES

Social Links:

Industry:
Biopharma Biotechnology Health Care

Founded:
2017-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.rheosrx.com

Total Employee:
11+

Status:
Active

Contact:
857-777-4242

Email Addresses:
[email protected]

Total Funding:
60 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Sitelinks Search Box


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

otonomy-logo

Otonomy

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

abbie-celniker_image

Abbie Celniker Board Member @ Rheos Medicines
Board_member

cary-pfeffer_image

Cary Pfeffer Board Member @ Rheos Medicines
Board_member

Current Employees Featured

nabil-uddin_image

Nabil Uddin
Nabil Uddin Vice President, Strategy & Business Development @ Rheos Medicines
Vice President, Strategy & Business Development
2022-02-01

abbie-celniker_image

Abbie Celniker
Abbie Celniker CEO @ Rheos Medicines
CEO

edward-driggers_image

Edward Driggers
Edward Driggers Chief Technology Officer @ Rheos Medicines
Chief Technology Officer

nirupama-subramanian_image

Nirupama Subramanian
Nirupama Subramanian COO @ Rheos Medicines
COO
2021-08-01

laurence-turka_image

Laurence Turka
Laurence Turka Chief Scientific Officer @ Rheos Medicines
Chief Scientific Officer

sanjay-keswani_image

Sanjay Keswani
Sanjay Keswani CEO @ Rheos Medicines
CEO

cary-pfeffer_image

Cary Pfeffer
Cary Pfeffer Chief Business Officer @ Rheos Medicines
Chief Business Officer

erika-pearce_image

Erika Pearce
Erika Pearce Founder @ Rheos Medicines
Founder

katerina-leftheris_image

Katerina Leftheris
Katerina Leftheris Sr. Vice President, Head of Drug Discovery @ Rheos Medicines
Sr. Vice President, Head of Drug Discovery
2022-04-01

barbara-s-fox_image

Barbara S. Fox
Barbara S. Fox CEO @ Rheos Medicines
CEO
2019-10-01

Founder


edward-pearce_image

Edward Pearce

erika-pearce_image

Erika Pearce

Investors List

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series A - Rheos Medicines

Official Site Inspections

http://www.rheosrx.com

  • Host name: 104.21.112.1
  • IP address: 104.21.112.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Rheos Medicines"

Rheos Medicines - Crunchbase Company Profile

Contact Email [email protected] Phone Number 857-777-4242 Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.See details»

Rheos Medicines - PitchBook

Information on valuation, funding, cap tables, investors, and executives for Rheos Medicines. Use the PitchBook Platform to explore the full profile.See details»

Rheos Medicines Company Profile - Office Locations, Competitors …

Rheos Medicines (formerly known as Immunometabolism Newco) is a biopharmaceutical company that develops medicines for metabolic pathways in immune cells. It offers …See details»

Rheos Medicines Announces Worldwide Collaboration with Roche …

Dec 19, 2019 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Rheos Medicines (Rheos), a biopharmaceutical company harnessing insights in immunometabolism to create a new class …See details»

Rheos Medicines - Overview, News & Similar companies - ZoomInfo

May 9, 2022 · Rheos Medicines contact info: Phone number: (857) 777-4242 Website: www.rheosrx.com What does Rheos Medicines do? Rheos Medicines is a biopharmaceutical …See details»

Rheos Medicines - VentureRadar

Website: http://www.rheosrx.com/ Develops precision medicine therapies for autoimmune diseases using immunometabolism insights, leveraging a proprietary platform to analyze multi …See details»

Rheos Medicines Announces Worldwide Collaboration with Roche …

Dec 19, 2019 · Rheos Medicines (Rheos), a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune …See details»

Rheos Medicines Forms Research Collaboration With ... - Business …

Oct 27, 2021 · CAMBRIDGE, Mass. & MARSEILLE, France-- ( BUSINESS WIRE )-- Rheos Medicines, a biopharmaceutical company bringing molecular targeting and precision treatment …See details»

Rheos Medicines Announces New Scientific Advisory Board …

Apr 14, 2022 · Rheos Medicines is a biopharmaceutical company developing precision medicines to treat autoimmune and inflammatory diseases by identifying and targeting the molecular …See details»

Rheos Medicines and PatientsLikeMe Announce Strategic …

Dec 17, 2020 · Rheos will incorporate de-identified patient-reported data from PatientsLikeMe along with proteomic, metabolomic, transcriptomic, and genetic data collected from …See details»

Rheos Medicines to Present Data at ACR 2021 for MALT1

Oct 13, 2021 · Rheos Medicines today announced it will present two poster presentations at ACR Convergence 2021, the annual meeting of the American College of Rheumatology which will …See details»

Rheos Medicines Presents Data Demonstrating Potential of MALT1 ...

Nov 1, 2021 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Rheos Medicines, Inc., a biopharmaceutical company bringing molecular targeting and precision treatment to …See details»

Rheos Medicines to Present at the Cowen and Company 40

Feb 18, 2020 · Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop novel therapeutics for patients with severe autoimmune …See details»

Rheos Medicines Receives FDA “Study May Proceed ... - Business …

Jul 20, 2022 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Rheos Medicines, a biopharmaceutical company bringing molecular targeting and precision treatment to autoimmune and …See details»

Rheos Medicines - VentureRadar

Similar Companies: Sitryx United Kingdom Privately Held We’re altering immune cell metabolism to resolve disease. Metabolic changes within cells of the immune system can drive the …See details»

Rheos Medicines Announces Publication of New Data to Support …

May 9, 2022 · Rheos Medicines today announced the peer-reviewed publication of preclinical data supporting MALT1 inhibition as a novel therapeutic strategy to treat autoimmune and …See details»

免费的新药情报数据库 - 药品查询、药品数据库、医药数据

Abstract A number of receptors are capable of activating the PI3K pathway in T cells, most prominently the T-cell receptor for antigen (TCR), the costimulatory receptor CD28, and the …See details»

Rheos Medicines to Present Data at ACR 2021 for MALT1 …

Oct 13, 2021 · Rheos Medicines is a biopharmaceutical company developing novel, small molecule medicines to treat autoimmune and inflammatory diseases with greater precision by …See details»

Rheos Medicines to Present Data at ASH 2021 for MALT1

Nov 4, 2021 · Rheos Medicines is a biopharmaceutical company developing novel, small molecule medicines to treat autoimmune and inflammatory diseases with greater precision by …See details»

Rheos Medicines Presents New Data Supporting MALT1

Dec 13, 2021 · Rheos’s lead product candidate, RHX-317, is a novel, small molecule MALT1 inhibitor initially in development for the treatment of chronic GVHD. The data will be presented …See details»

linkstock.net © 2022. All rights reserved